Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I haven't looked at this spac yet. If the deal goes thru, I'd wait for it to settle before considering.
Most of the canna spacs have been absolute dog dung. Maps, leafly, the parent company, greenrose, Ceres, glass house..etc
I'd prefer to add to a proven operator versus an unknown / over priced spac deal.
Why take the risk when you can buy leaders on sale?(my initial thoughts, without looking too closely at it.)
Trul, GTI, verano, Cura, Cresco, AYR, terrascend ..etc.
Glass house is the only one I currently own, and bought in the mid $3s...heavily discounted.
With markets on suspect footing right now, I'm raising cash levels & only allocating to leadership.
Good to see it bounce. We were getting close to March 2020 lows :)
Interview: 1933 Industries Inc. w/ Paul Rosen
Jan 31, 2022
Canna Comp Sheet - Read the Footnotes - Flag any issues
$TCNNF $CURLF $GTBIF $CRLBF $VRNOF $TRSSF $AYRWF $JUSHF $FFNTF $CCHWF $AAWH $ACRDF $ACRHF $RWBYF $CNTMF $HBORF $MRMD $CXXIF $SHWZ $BMMJ $GLASF $CPTR $PLNHF $GDNSF $LOWLF $INLB $MMNFF $GLDFF $GRAMF $GAEGF $VEXTF
🇺🇸 Canna Comp Sheet - Read the Footnotes - Flag any issues $TCNNF $CURLF $GTBIF $CRLBF $VRNOF $TRSSF $AYRWF $JUSHF $FFNTF $CCHWF $AAWH $ACRDF $ACRHF $RWBYF $CNTMF $HBORF $MRMD $CXXIF $SHWZ $BMMJ $GLASF $CPTR $PLNHF $GDNSF $LOWLF $INLB $MMNFF $GLDFF $GRAMF $GAEGF $VEXTF pic.twitter.com/v8MIaiQ17w
— 🇺🇦 Free CashFlow (@cashflow_free) February 1, 2022
Insanely cheap, but here we are!
Flirting w/ March 2020 lows
All my stink bids filled & added a couple more for good measure:)
Lifeist Wellness Inc. - Lifeist’s Consumer-focused Roilty Brand Wins Coveted “Canadian LP Brand of Year” Award at ADCANN
https://lifeist.com/news/press-releases/press-releases-details/2022/Lifeists-Consumer-focused-Roilty-Brand-Wins-Coveted-Canadian-LP-Brand-of-Year-Award-at-ADCANN/default.aspx
Bouncing w/ strong volume in Canada over the past few days, especially in dark pools.
https://www.stockwatch.com/Quote/Detail?C:LFST
USA volume picking up a bit too.
Yep, they've killed the capital structure to benefit acb & themselves at the expense of retail investors, sadly.
My shares came over from phivida, which was just as bad, unfortunately.
I dont really see much of a path for them.
They're not focused on building much of anything.
Too focused on themselves, and handing out low priced shares & warrants.
All imo
Glta
Gw
Nice little round trip here.
Adding a few here.
FIL
Teva Israel steps into the ring to begin distributing medical cannabis products
Teva Israel partners with Cannbit-Tikun Olam to distribute medical cannabis products that may provide additional treatment options and respond to unmet medical needs of patients.
By ZACHY HENNESSEY Published: DECEMBER 26, 2021 15:55
https://www.jpost.com/health-and-wellness/article-689805
Teva Israel and Cannbit-Tikun Olam signed an exclusive and mutual collaboration agreement, in which Cannbit-Tikun Olam will produce several medical cannabis products, administered as oils rich in THC and CBD, for Teva Israel. This will be done according to Teva’s instructions and stringent standards, and the products will be exclusively marketed and distributed by Teva in Israel and the Palestinian Authority.
The oils are based on strains developed by Cannbit-Tikun Olam and selected exclusively by Teva Israel due to their safety profile and strong therapeutic efficacy. In the future, and to the extent possible, the cannabis oils will also be marketed by Teva in Ukraine, where the
government is currently developing regulations.
“The medical cannabis arena is developing and being professionalized at a dizzying pace in Israel, and there is more openness to it in Israel and worldwide,” said Yossi Ofek, CEO of Teva Israel.
“Today, it is clear to many in the pharmaceutical industry and in the medical community that use of oils produced from specific cannabis strains may provide additional treatment options and respond to unmet medical needs of patients.
We decided to join forces with Cannbit-Tikun Olam following an in-depth and lengthy review and I have no doubt that the medical cannabis oils Cannbit-Tikun Olam produces – according to Teva’s high quality and safety standards – will help us realize our goal of improving the lives of patients.”
.016 pre rs
Lol
The execs sold themselves. 01 plus a warrant before the rs.
They literally handed themselves the majority of the company then sold their cost out on fake prs.
I bet they begin the P&D into the new year.
Scam company.
Yep, chopping around in no man's land for now.
Fire & Flower To Acquire Pineapple Express Delivery
Thursday, December 9, 2021
https://www.accesswire.com/676739/Fire-Flower-To-Acquire-Pineapple-Express-Delivery
Interview 12/8/21 - Žiga Drew of @Origin_Trail at http://CoinAgenda.com
Žiga Drew of @Origin_Trail at https://t.co/ezDs68CBGw! https://t.co/APChBXeDAc
— Washington Elite (@WashingtonElite) December 8, 2021
Interesting project.
TRAC
Interested if we test 52 week lows?...21-ish.
Weird stuff happens late late December.
Between tax loss season and low liquidity, never know.
Have a couple stink bids in.
Ready and waiting.
Gotta get this suckered pumping again!
STORJ
Thanks, hopefully!
I feel comfortable peppering in some adds down here.
No problem adding under $100M market cap.
GL
Hopefully different than ehave, but history suggests caution.
Same ceo.
Scam/fake LOI ANNOUNCED today
CEO has history of never executing on any LOI.
Look at ehave.
No worries, plenty of time to buy this trash all the way down: ) zero
Added some at .26 today. lol
Lifeist Subsidiary Mikra Cellular Sciences to Launch First Product “CELLF” to Combat Brain Fog and Unlock Healthy Aging, Announces U.S. Patent Application and Pre-Clinical Study 12/06/2021
https://lifeist.com/news/press-releases/press-releases-details/2021/Lifeist-Subsidiary-Mikra-Cellular-Sciences-to-Launch-First-Product-CELLF-to-Combat-Brain-Fog-and-Unlock-Healthy-Aging-Announces-U.S.-Patent-Application-and-Pre-Clinical-Study/default.aspx
- Mikra patent focusing on novel cellular therapeutic targeting systemic fatigue
- Mikra partners with InVivo Biosystems for pre-clinical trials to strengthen patent application and generate further data confirming expression pathways for genes
TORONTO, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to enable you to find your path to wellness, today announced that its newly launched biosciences and consumer wellness subsidiary, Mikra Cellular Sciences Inc. (“Mikra”), is poised to launch its first product “CELLF”, a novel cellular therapeutic compound targeting systemic fatigue. As part of pre-launch activities of CELLF, Mikra has filed a patent application with the United States Patent and Trademark Office and partnered with InVivo Biosystems, Inc. (“InVivo Biosystems”) for pre-clinical trials to strengthen its patent claim.
“The real health crisis isn’t reduced longevity — we’re living longer than we have in the past. It’s extended morbidity that’s the problem. While we’re all familiar with mortality, morbidity is attributable to age-related diseases that lower your quality of life which is why so many of us when we hit our 30’s, 40’s and 50’s experience multiple physiological and mental walls — notably brain fog, fatigue, and inflammation. This all happens at a cellular level, and it can cascade into poor sleep, mood drops, and an inability to enjoy life like you want to,” said Faraaz Jamal, COO of Lifeist and CEO of Mikra. “With that in mind, I’m extremely excited to present Mikra’s first product, CELLF (pronounced “self”). We engineered this product for everyone who has started to feel like their biological age is affecting their everyday performance and ability to feel like the best version of themselves.”
Continued Jamal, “CELLF works at a cellular level to help combat systemic fatigue, inflammation, and brain fog by promoting the creation of mitochondria and subsequently increasing their efficiency. This is in addition to the upregulation and downregulation of certain cellular detoxification pathways that can remove the buildup of senescent (old/dysfunctional) cells that may cause excessive chronic inflammation and uncontrolled cell division.”
CELLF - A science-backed cellular therapeutic, treating systemic fatigue and low-grade cellular inflammation
CELLF is manufactured in a proprietary oxygen-deprived environment to maintain biopotency and bioavailability with clinically tested United States Food & Drug Administration (FDA) certified GRAS (generally recognized as safe) bioactive ingredients. The CELLF compound delivery system is a two-stage, patented mechanism — it is first bound to a transferrin glycoprotein and then encapsulated within a liposome. This allows safe passage of CELLF through the gastric environment and delivery directly into the blood plasma. The result is optimal delivery of our compound with minimal degradation to the best site of absorption. CELLF will be shipped in a package containing 30 X 10ml single-serve sachets to prevent oxidation and maximize bioavailability.
“You’ve got to satisfy two conditions for a product like this to work. The first is that the molecules within the compound need to be backed by rigorous science. The second is that you need to deliver it effectively into your body, and more specifically, your cells so that it is maximally absorbed. Very few products satisfy the first, let alone the second,” said Jamal. “As one of my lifelong heroes, Carl Sagan once said, ‘extraordinary claims require extraordinary evidence’, which is why we’ve partnered with Invivo Biosystems to prove and strengthen our patent claim that CELLF does both.”
Mikra Partners with InVivo Biosystems
Mikra has partnered with InVivo Biosystems, experts in genetic model creation and in vivo testing, to strengthen its patent application by conducting a pre-clinical study identifying genetic signatures and pathways associated with average human healthspans and to test the effects of CELLF on healthy aging.
“We are proud to partner with Mikra in developing a family of healthy living products that reduce biological aging. At InVivo Biosystems, we take a systematic, multi-omics approach to make gene-by-gene discoveries and uncover the different genetic pathways that are up or down regulated during aging. The InVivo Longevity Platform measures the complex interplay of cellular proliferation, autophagy, mitochondrial oxidative stress, genetic predisposition, and transcriptional changes that occur during aging,” said Chris Hopkins, PhD, Chief Science Officer at InVivo Biosystems. “In our collaboration with Mikra, we are exploring how its flagship formulation, CELLF, increases the efficiency of mitochondrial ATP production and cellular respiration. Using the InVivo Longevity Platform, we measure at the molecular level how Mikra’s CELLF formulation can counter periodic bouts of fatigue by providing improved cellular respiration. In our partnership, we will be generating the science-based evidence that Mikra can use as further backbone for their intellectual property claims. Here at InVivo Biosystems we are also excited to continue partnering with Mikra in the future to uncover further how CELLF, and their future product lines, can create a new baseline for healthy living after 30.”
CELLF Product & Community Launch
“I’m very excited about adding incremental value to Lifeist shareholders and unlocking the earnings potential of Mikra and subsequently Lifeist. We’re taking the first steps here with bringing something novel to the market, validating and protecting it. But let’s be clear, it’s only the first step,” said Meni Morim, CEO of Lifeist. “The initial traction Mikra has had around the pre-launch has been very promising — to grow to a community of nearly 20,000 with a huge level of engagement, in such a short amount of time and with no sign of stopping is a testament to the team’s expertise and validates the consumer’s desire for this type of product.”
Mikra’s CELLF will be available for pre-sale in mid-Q1 2022 with a waitlist sign up available at www.wearemikra.com. CELLF will be available on www.wearemikra.com and Amazon following the pre-sale for full public launch.
Follow Mikra’s journey on your favorite social media platform with @wearemikra.
About Mikra, Cellular Sciences Inc.
Mikra is a biological sciences and consumer wellness company on a mission to increase your healthspan by focusing on the tiniest aspect of your health: the cell. People are made up of over 37 trillion cells with a variety of different sizes, shapes, functions and lifespan. These cells are responsible for energy, happiness, recovery potential and so much more. Mikra is exploring the link between changes at a cellular level and the cascading effects it can have on health.
About InVivo Biosystems, Inc.
InVivo Biosystems, an expert in genetics, delivers scientific proof and evidence for ingredients at the molecular and cellular level via a proprietary analytical approach. Its analytical platform helps branded ingredient developers and manufacturers substantiate their product claims, file IP patents, or refine their formulations using the best science backed measure of outcome. Managed by experienced PhD scientists, InVivo Biosystems’ gene expression platform can help find new applications for novel ingredients, discover new molecules, and conduct proof-of-concept studies for therapeutic purposes. Visit www.invivobiosystems.com/longevity for more information.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness revolution, Lifeist is a portfolio of wellness companies leveraging advancements in science and technology to enable individuals to find their personalized path to wellness. Portfolio business units include: CannMart, which operates a B2B wholesale distribution business facilitating recreational sales to Canadian provincial government control boards and the CannMart.com marketplace which provides Canadian medical customers with a diverse selection of cannabis products from a multitude of federally licensed cultivators and its U.S. customers with access to hemp-derived CBD and smoking accessories; Australian Vapes, the country’s largest online retailer of vaporizers and accessories; Findify, a leading AI-powered search and discovery platform; and Mikra, a biosciences and consumer wellness company seeking to develop innovative therapies for cellular health and recovery.
Information on Lifeist and its businesses can be accessed through the links below:
www.lifeist.com
www.cannmart.com
www.everyonedoesit.co.uk
www.australianvaporizers.com.au
www.wearemikra.com
Contacts
Lifeist Wellness Inc.
Meni Morim, CEO
Matt Chesler, CFA, Investor Relations
Ph: 647-362-0390
Email: ir@lifeist.com
Scam company
idk how the wellness launch works out? Might be interesting, but will take more time. 1st half of 2022, Meni & team are slow w/ everything they touch. :)
TAM expansion good, but they're trying to introduce a whole new product to the wellness category?
Oh well, we'll see how it plays out.
Thanksgiving was great, hope the same for you!
Cheers
Lifeist Launches Mikra, a Biosciences and Consumer Wellness Company Operating at the Intersection of Cellular Health and Human Aspiration
Wide Ranging Collaboration with Baseball Legend Jose Bautista Who Will Join as Advisor to and Investor in Lifeist and Mikra
Limited Pre-Sale from Mikra Expected Early Q1 2022
https://ceo.ca/@nasdaq/lifeist-launches-mikra-a-biosciences-and-consumer
TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF), a health-tech company that leverages advancements in science and technology to enable you to find your path to wellness, today announced the launch of a new biosciences and consumer wellness company named Mikra, Cellular Sciences Inc. (“Mikra”), incorporated in the U.S. As part of the nutraceuticals endeavour, the Company is collaborating with MLB six time All-Star, three time Silver Slugger and recent Olympic Bronze medal winner Jose Bautista, who is joining the Company as an advisor and is making a direct equity investment in Lifeist.
“It’s taken time, but Lifeist has now taken a major step in our transition to a portfolio of wellness companies,” said Meni Morim, Lifeist’s CEO. “Mikra is a breakthrough company seeking to unlock cellular potential and maximize the health of humans. With the launch of Mikra, Lifeist enlarges its total addressable market (TAM) to include the growing $105 billion nutraceutical market in the U.S. alone1. We believe that Mikra will help consumers discover new pathways to individualized wellness whilst simultaneously rebuilding our shareholders’ value.”
Continued Morim, “Mikra intends to bridge the scientific gap between cellular health and consumer wellness. In collaboration with Mikra’s first ‘human inspiration’ Jose Bautista, we’re applying and developing new applications of bioactive compounds to develop innovative consumer products and delivery methods to increase your body’s cellular ability to recover from any stress you put it under. Whether that’s a grueling workout, overindulgence of alcohol or just not enough sleep, inevitably, when you hit 30 it becomes harder to bounce back from these situations. And as we know, life doesn’t get easier after 30, so that internal damage compounds and suddenly, you’re chronically fatigued. Mikra is here to give your cellular system the tools it needs to eradicate that internal stress and bounce back quicker. As an influential superstar athlete, Jose brings Mikra a unique ability to reach high-performance athletes and develop solutions that will assist in their recovery and performance at a cellular level.”
Introducing Mikra
Mikra is driven by a single element; focusing on the tiniest aspect of one’s health that has the largest impact - the cell. People are made up of over 37 trillion cells with a variety of different sizes, shapes, functions and lifespan. These cells are responsible for energy, happiness, recovery potential and so much more. Mikra is exploring the link between changes at a cellular level and the cascading effects it can have on health.
Mikra’s review of the nutraceuticals market uncovered an exceptional amount of misleading marketing and hyperbolized claims in the industry. Consumer insights have confirmed that people tend to think if they take 30 pills a day, they will cover all their bases and be protected for the future. At Mikra, we seek to not only create wellness products that cut through all that noise, but build a pipeline and a community that continues to innovate and push science forward.
“Mikra is on a mission to increase your healthspan – we want to maximize the number of years where you feel healthy, where you feel you can do anything”, said Faraaz Jamal, COO of Lifeist and CEO of Mikra. “When you hit your 30s, there’s a transition that happens at a cellular level and it becomes harder to perform mentally and physically at the levels you expect or were used to. Science is finally catching up and we’re investigating bioactive compounds and cellular therapeutics as a way to combat this phenomenon and also prevent it – it’s extremely exciting.”
Continued Jamal, “Having strategized, built and led teams within the wellness space, specifically within nutraceuticals that rapidly scaled product lines from zero to over $250 million of revenue inside of three years, I cannot begin to express how excited I am for our disruptive Mikra product pipeline as well as our unique athleticism focused therapeutic in progress with Jose. We believe the potential applications and market opportunity is staggering. While we are deep in formulation towards Jose’s first product, we are simultaneously looking at consumer applications that focus on sleep quality and neuroplasticity as well as a hangover cure. We’re excited to be potentially presenting a new baseline for health and wellness and subsequently, your happiness.”
Mikra is in the final production stages of its first product (codename: Alpha-01) which is manufactured in a proprietary, oxygen-deprived environment, utilizing clinically tested, clinical-grade ingredients sourced only from the U.S. and Japan. Mikra’s first product seeks to become one of the world’s most potent bioactive compounds targeting cellular stress. Engineered for humans who have run up against that mental and physical wall when they hit 30 years old, Alpha-01 works at a cellular level to effectively increase one’s everyday performance and potential. Pre-sale activities are scheduled for December 2021 with full distribution across our upcoming in-house direct-to-consumer platform and through Amazon in late Q1 2022 with offline distribution scheduled in Q4 2022.
Wide Ranging Collaboration with Baseball Superstar Jose Bautista
“We’re honoured and excited to collaborate with Jose,” said Jamal. “Improving recovery and performance is an essential and growing focus, not just in professional athletics, but in recreational activities and general wellness overall. Jose and I agree that there’s a significant opportunity to bring a science-backed, intracellular therapeutic to boost recovery and potential so that people at all levels of sports and physical activity can play harder and recover quicker. This is only the beginning and we’re extremely excited to advance academic breakthroughs and pioneer applications of bioactive compounds across consumer wellness innovations as well as explore FDA-regulated cellular therapeutics targeting specific syndromes via our upcoming medical advisory board to help realize our mission and drive incremental value to our shareholders.”
Commented Jose Bautista, “As someone who takes health as well as physical and mental potential very seriously, I can say that I have very high standards of what I put in my body. Mikra offers something different within the nutraceutical category – the innovation capabilities and track record of the team, as well as the science-based approach makes this a unique opportunity.”
“I trust the science and believe passionately in the mission and product,” added Bautista. “Ever since my first conversation with Faraaz, I realized there was a significant opportunity to take what he was engineering and combine it with my professional experience. Many professional athletes during their careers experience injury or a decline in health with normal wear-and-tear, and we do our very best to push past these limits –sometimes to our detriment. I’m joining Mikra to help change that. Our values and goals are aligned: pioneer and launch solutions containing clinically proven, cutting-edge compounds, and bring about lasting improvements to health and performance. We’re here to do things differently and we’re here to win.”
The collaboration involves the following:
Consulting: Mr. Bautista is taking on the role of Wellness Advisor to Lifeist and Mikra, whose wisdom Mikra will seek out and with whom Lifeist will seek to collaborate with whenever possible to advance mutual interests in wellness. In this role, Mr. Bautista will act as an ambassador to Mikra, participating in the launch of Mikra’s first product and any subsequently mutually developed products. Consideration for Mr. Bautista’s consulting services is in the form of options in the Company only.
Collaboration Agreement: Mr. Bautista looks forward to working strategically with Mikra on their product roadmap and advising on certain aspects of distribution and messaging, and collaborating to launch on an exclusive basis cellular health products and accessories the first of which is targeted for distribution in the U.S. by mid-2022.
Direct Equity Investment: The TSX Venture Exchange has approved and the Company has completed a non-brokered private placement by two subscribers including an investment vehicle of Mr. Bautista, of an aggregate of 2,214,287 units of Lifeist (each a “Unit”) at a price of $0.07 per Unit for aggregate gross proceeds of C$155,000.09 (the “Offering”). Each unit consists of one common share of Lifeist (each a “Share”) and one Share purchase warrant (a “Warrant”). Each Warrant entitles subscribers to acquire one Share at an exercise price of $0.11 until November 29, 2024. The proceeds of the Offering will be used towards the development of Mikra’s product pipeline. The Shares, which, calculated as at the date of this announcement, constitutes approximately 0.55% of the issued Shares of Company and the Warrants are subject to a statutory hold period of four months and one day. Any Warrants exercised on or prior to March 30, 2022 will also be subject to the same hold period ending on March 30, 2022.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness revolution, Lifeist is a portfolio of wellness companies leveraging advancements in science and technology to enable individuals to find their personalized path to wellness. Portfolio business units include: CannMart, which operates a B2B wholesale distribution business facilitating recreational sales to Canadian provincial government control boards and the CannMart.com marketplace which provides Canadian medical customers with a diverse selection of cannabis products from a multitude of federally licensed cultivators and its U.S. customers with access to hemp-derived CBD and smoking accessories; Australian Vapes, the country’s largest online retailer of vaporizers and accessories; Findify, a leading AI-powered search and discovery platform; and Mikra, a newly launched biosciences and consumer wellness company seeking to develop innovative therapies for cellular health and recovery.
Information on the Company and its many products can be accessed through the links below:
www.lifeist.com
www.cannmart.com
www.everyonedoesit.co.uk
www.australianvaporizers.com.au
www.wearemikra.com
Contacts
Lifeist Wellness Inc.
Meni Morim, CEO
Matt Chesler, CFA, Investor Relations
Ph: 647-362-0390
Email: ir@lifeist.com
Any day now.
STORJ
Light one up!
A major move toward marijuana legalization sparked a fiery rally in pot stocks into the close.
@TimSeymour
breaks down the action and what it could mean for the industry.
Light one up!
— CNBC's Fast Money (@CNBCFastMoney) November 5, 2021
A major move toward marijuana legalization sparked a fiery rally in pot stocks into the close.@TimSeymour breaks down the action and what it could mean for the industry. pic.twitter.com/uDJphRoMRA
Some potential there too.
Read High Tide's piece from last night.
https://www.newswire.ca/news-releases/largest-alberta-based-cannabis-retailer-welcomes-legislation-to-shift-cannabis-e-commerce-to-private-sector-835251945.html
It took a lot longer than expected, but great to see CannMart Labs get to this point.
Demand & margins are high on these products, which should help Cannmart gain market share and attract more attn/sale to their medical biz & retail distribution partners.
"It’s also worth noting that an initial order for the Roilty-branded vape pen, Henry the Grape Ape, that was manufactured by a co-packer sold through CannMart Inc. into Alberta, sold out within seven days and additional quantities have been ordered to meet demand.”
Imagine being able to buy these products & expensing / writing off your annual purchases on your tax returns.
Can't do that w/ black market or rec purchases in Canada.
Interested to see what they have cooking w/ the launch of wellness category.
The dealers license for Cannmart will be a major differentiator in Canada under their medical biz. Not aware of other marketplaces or LPs in pursuit of one either.
I re-loaded a bunch of new shares under a dime & will continue to add thru Dec 2021.
GLTA
GW
Nice morning.
Pump it!
Nice moirning
Looking good!
ALGO
Suspect a potential opportunity to buy a big dip post RS.
Ultimately, it'll be good to get this POS off the OTC.
It's tradable, but will always be a POS company w/ a POS / sub-par management.
Geeez...
Can't say we're surprised :)
Yup, I hold a core and trade around it.
Lifeist Pre-Announces Increased Estimated Revenue and Expanded Margins for Q3 2021
https://finance.yahoo.com/news/lifeist-pre-announces-increased-estimated-203600814.html
As previously reported in its Current Report on Form 8-K filed with the Securities and Exchange Commission on September 7, 2021, Ondas Holdings Inc. (the “Company”) will host a virtual investor presentation focused on American Robotics from 10:00 am – Noon ET on Tuesday, September 28, 2021. Attached hereto as Exhibit 99.1 and incorporated into this Item 7.01 by reference is the presentation that will be used by the Company during the presentation.
The information in this Item 7.01 (including Exhibit 99.1) is being furnished and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise be subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01. Financial Statement and Exhibit.
https://ih.advfn.com/stock-market/NASDAQ/ondas-ONDS/stock-news/86151619/current-report-filing-8-k
(d) Exhibits
Exhibit No. Description
99.1 Presentation, dated September 28, 2021.